+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tumor"

Oncology Collaboration and Licensing Deals 2019-2024 - Product Thumbnail Image

Oncology Collaboration and Licensing Deals 2019-2024

  • Report
  • April 2024
  • 1800 Pages
  • Global
From
Immuno-Oncology Clinical Trials Market Report 2023-2033 - Product Thumbnail Image

Immuno-Oncology Clinical Trials Market Report 2023-2033

  • Report
  • September 2023
  • 249 Pages
  • Global
From
Oncology Biomarkers: Global Markets - Product Thumbnail Image

Oncology Biomarkers: Global Markets

  • Report
  • June 2023
  • 186 Pages
  • Global
From
Generic Oncology Sterile Injectable Global Market Report 2024 - Product Thumbnail Image

Generic Oncology Sterile Injectable Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Oncology-based In-Vivo CRO Global Market Report 2024 - Product Thumbnail Image

Oncology-based In-Vivo CRO Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
From
Innovation Waves in Immuno-oncology Therapy Development - Product Thumbnail Image

Innovation Waves in Immuno-oncology Therapy Development

  • Report
  • February 2024
  • 75 Pages
  • Global
From
Global Precision Oncology Market Trends and Growth Opportunities - Product Thumbnail Image

Global Precision Oncology Market Trends and Growth Opportunities

  • Report
  • November 2023
  • 78 Pages
  • Global
From
Loading Indicator

The tumor market within the context of oncology is a rapidly growing sector of the healthcare industry. It is focused on the diagnosis, treatment, and prevention of cancer. This market includes a wide range of products and services, such as drugs, medical devices, diagnostics, and imaging technologies. It also includes services such as radiation therapy, chemotherapy, and immunotherapy. The tumor market is driven by the increasing prevalence of cancer, advances in technology, and the development of new treatments. It is also driven by the increasing demand for personalized medicine and the need for better patient outcomes. The tumor market is highly competitive, with many companies competing for market share. Some of the major players in the market include Roche, Novartis, Merck, AstraZeneca, Pfizer, and Bristol-Myers Squibb. Other companies in the market include AbbVie, Amgen, Celgene, Eli Lilly, and GlaxoSmithKline. Show Less Read more